Effect of the KCNQ potassium channel opener retigabine on single KCNQ2/3 channels expressed in CHO cells

Journal of Physiology

Volumn 549, Issue 1, 2003, Pages 57-63

  Tatulian, L ^a   Brown, D A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL STIMULATING AGENT; PROTEIN SUBUNIT; RETIGABINE; POTASSIUM CHANNEL KCNQ2; POTASSIUM CHANNEL KCNQ3;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL KINETICS; CELL MEMBRANE CONDUCTANCE; CHANNEL GATING; CHO CELL; CONTROLLED STUDY; DRUG MECHANISM; HYPERPOLARIZATION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROBABILITY; PROTEIN EXPRESSION; STEADY STATE; CELL ATTACHED PATCH CLAMP; CHO CELL LINE; POTASSIUM CONDUCTANCE; POTASSIUM CURRENT;

ANIMALS; ANTICONVULSANTS; CARBAMATES; CHO CELLS; CRICETINAE; HUMANS; ION CHANNEL GATING; KCNQ2 POTASSIUM CHANNEL; KCNQ3 POTASSIUM CHANNEL; KINETICS; PHENYLENEDIAMINES; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; TRANSFECTION;

EID: 0038187795     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2003.039842     Document Type: Article

References (25)

1. Biervert C, Schroeder BC, Kubisch C, Berkovic SF, Propping P, Jentsch T & Steinlein OK (1998). A potassium channel mutation in neonatal human epilepsy. Science 279, 403-406.
2. Brown D (1988). M-currents: an update. Trends Neurosci 11, 294-299.
3. Charlier C, Singh NA, Ryan SG, Lewis TB, Reus BE, Leach RJ & Leppert M (1998). A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nature Genetics 18, 53-55.
4. Colquhoun D & Sigworth FJ (1995). Fitting and statistical analysis of single channel records. In Single Channel Recording, 2nd edn, ed. Sakmann B & Neher E, pp. 483-587. Plenum, New York.
5. + channels. Soc Neurosci Abstr 217.2.
6. Hadley JK, Noda M, Selyanko AA, Wood IC, Abogadie FC & Brown DA (2000). Differential tetraethylammonium sensitivity of KCNQ1-4 potassium channels. Br J Pharmacol 129, 413-415.
7. Hadley JK, Passmore GM, Tatulian L, Al-Qatari M, Ye F, Wickenden AD & Brown DA (2003). Stoichiometry of expressed KCNQ2/KCNQ3 channels and subunit composition of native ganglionic M-currents deduced from block by tetraethylammonium (TEA). J Neurosci (in the Press).
8. Kubisch C, Schroeder BC, Friedrich T, Lutjohann B, El-Amraoui A, Marlin S, Petit C & Jentsch TJ (1999). KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell 96, 437-446.
9. Lerche C, Scherer CR, Seebohm G, Derst C, Wei AD, Busch AE & Steinmeyer K (2000). Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity. J Biol Chem 275, 22395-22400.
10. + current due to a novel mutation in KCNQ2 causes neonatal convulsions. Ann Neurol 46, 305-312.
11. Main MJ, Cryan JE, Dupere JRB, Cox B, Clare JJ & Burbidge SA (2000). Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. Mol Pharmacol 58, 253-262.
12. Marrion NV (1997). Control of M-current. Ann Rev Physiol 59, 483-504.
13. Rostock A, Tober C, Rundfeldt C, Barsch R, Engel J, Polymeropoulos EE, Kutscher B, Loscher W, Homack D, White HS & Wolf HH (1996). D-23129, a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Res 23, 211-223.
14. Rundfeldt C & Netzer R (2000). The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells transfected with human KCNQ2/3 subunits. Neurosci Lett 282, 73-76.
15. Schroder RL, Jesperson T, Christopherson P, Strobaek D, Jensen BS & Oleson SP (2001). KCNQ4 channel activation by BMS-204352 and retigabine. Neuropharmacology, 40, 888-898.
16. Schroeder BC, Hechenberger M, Weinreich F, Kubisch C & Jentsch TJ (2000). KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents. J Biol Chem 31, 24089-24096.
17. Selyanko AA & Brown DA (1996). Intracellular calcium directly inhibits potassium M channels in excised membrane patches from rat sympathetic neurons. Neuron 16, 151-162.
18. Selyanko AA & Brown DA (1999). M-channel gating and simulation. Biophys J 77, 701-713.
19. Selyanko AA, Hadley JK & Brown DA (2001). Properties of single M-type KCNQ2/KCNQ3 potassium channels expressed in mammalian cells. J Physiol 534, 15-24.
20. Singh NA, Charlier C, Stauffer D, Dupont BR, Leach RJ, Melis R, Ronen GM, Bjerre I, Quattlebaum T, Murphy JV, McHarg ML, Gagnon D, Rosales T, Peiffer A, Anderson VE & Leppert M (1998). A novel potassium channel gene KCNQ2, is mutated in an inherited epilepsy of newborns. Nature Genetics 18, 25-29.
21. Tatulian L, Delmas P, Abogadie FC & Brown DA (2001). Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J Neurosci 21, 5535-5545.
22. Tober C, Rostock A & Bartsch R (1996). D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures. Eur J Pharmacol 303, 163-169.
23. Wang H-S, Pan Z, Shi W, Brown BS, Wymore R, Cohen IS, Dixon JE & McKinnon D (1998). KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 282, 1890-1893.
24. Wickenden AD, Yu W, Zou A, Jegla T & Wagoner PK (2000). Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/3 potassium channels. Mol Pharmacol 58, 591-600.
25. Yang W-P, Levesque PC, Little WA, Condor ML, Shalaby FY & Blanae MA (1997). KvLQT1, a voltage-gated potassium channel responsible for human arrhythmias. Proc Natl Acad Sci U S A 94, 4017-4021.